Objective
=========

To study the influence of gender, menopausal status, smoking, previous nonvertebral fractures, hormone replacement use, disease duration and glucorticoid use for low bone mineral density (BMD) in rheumatoid arthritis patients.

Method
======

A cross-sectional study in 177 patients (164 females and 13 males). BMD was assessed in the spine and femoral neck in a DXA Norland XR26. Low BMD was defined as *Z*score \< -1 compared with our normal population. Student\'s *t*test, logistic regression, stepwise logistic regression and multiple logistic regression were calculated.

Results
=======

See Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"} overleaf.

###### 

Risk factors for low bone mineral density (BMD) in the age-adjusted and sex-adjusted model

  Variable               Comparison     Spine, odds ratio (95% confidence interval)   *P*      Femoral neck, odds ratio (95% confidence interval)   *P*
  ---------------------- -------------- --------------------------------------------- -------- ---------------------------------------------------- --------
  Female                 Male           1.43 (0.44--4.68)                             0.55     1.35 (0.41--4.47)                                    0.63
  Menopause              Premenopause   0.96 (0.51--1.81)                             0.92     1.34 (0.72--2.52)                                    0.49
  Ever smoking           Never smoked   0.88 (0.42--1.89)                             0.76     1.19 (0.57--2.51)                                    0.64
  Nonvertebral                                                                                                                                      
   Fracture              No fracture    0.98 (0.28--3.39)                             0.98     1.38 (0.42--4.53)                                    0.59
   Ever HRT              Never HRT      0.41 (0.15--1.15)                             0.09     0.30 (0.14--1.10)                                    0.08
  Disease duration                                                                                                                                  
   1--5 years            \< 1 year      1.51 (0.55--4.06)                             0.42     3.07 (0.91--10.34)                                   0.07
   5 years               \< 1 year      2.54 (1.06--6.05)                             0.04     7.46 (2.47--22.48)                                   0.0001
  Corticosteroids                                                                                                                                   
   Ever                  Never          3.19 (1.56--6.54)                             0.001    2.07 (1.06--4.02)                                    0.03
   \< 7.5 mg daily       Never          2.75 (1.28--5.88)                             0.009    1.83 (0.89--3.74)                                    0.09
   7.5 mg daily          Never          4.29 (1.81--10.20)                            0.001    2.61 (1.15--5.91)                                    0.02
   \< 5 g cummulative    Never          1.51 (0.56--3.99)                             0.42     1.04 (0.41--2.67)                                    0.93
   5--10 g cummulative   Never          2.61 (0.99--6.88)                             0.05     0.95 (0.34--2.63)                                    0.92
   \> 10 g cummulative   Never          5.11 (2.3--11.29                              0.0001   4.05 (1.9--8.61)                                     0.0001

Low BMD, *Z*score \< -1 compared with our normal population. HRT, hormone replacement therapy.

###### 

Multivariable analysis of risk factors for low bone mineral density (BMD)

  Variable              Comparison     Spine, odds ratio (95% confidence interval)   *P*      Femoral neck, odds ratio (95% confidence interval)   *P*
  --------------------- -------------- --------------------------------------------- -------- ---------------------------------------------------- ------
  Menopause             Premenopause   0.85 (0.42--1.74)                             0.66     1.08 (0.52--2.52)                                    0.83
  Ever HRT              Never HRT      0.69 (0.22--2.16)                             0.53     0.55 (0.17--1.76)                                    0.31
  Disease duration                                                                                                                                 
   1--5 years           \< 1 year      0.95 (0.30--3.07)                             0.94     2.31 (0.63--8.52)                                    0.21
   5 years              \< 1 year      1.22 (0.41--3.62)                             0.72     4.83 (1.44--16.21)                                   0.01
  Corticosteroids                                                                                                                                  
   Never                Ever           0.87 (0.38--2.03)                             0.75     0.69 (0.21--2.23)                                    0.54
   \< 5 g cummulative   Never          1.35 (0.37--4.89)                             0.65     1.62 (0.45--5.89)                                    0.46
   \>10 g cummulative   Never          5.39 (1.95--14.86)                            0.0001   3.73 (1.23--11.26)                                   0.02

Low BMD, *Z*score \< -1 compared with our normal population. HRT, hormone replacement therapy.

Conclusions
===========

When risk factors for low BMD were analyzed in an age-adjusted and sex-adjusted model, disease duration and glucorticoid use appeared as significant risk factors for low BMD. In a multivariate analysis, disease duration longer than 5 years appears as independently significant for low femoral neck BMD. Related to glucorticoid use, only more than 10 g cummulative dose was independently significant for low BMD both in the spine and femoral neck.
